ECSP003564A - SELECTIVE ANTAGONISTS OF THE RECEIVER OF iG1uR5 FOR THE TREATMENT OF MIGRAINE - Google Patents
SELECTIVE ANTAGONISTS OF THE RECEIVER OF iG1uR5 FOR THE TREATMENT OF MIGRAINEInfo
- Publication number
- ECSP003564A ECSP003564A ECSP003564A ECSP003564A EC SP003564 A ECSP003564 A EC SP003564A EC SP003564 A ECSP003564 A EC SP003564A EC SP003564 A ECSP003564 A EC SP003564A
- Authority
- EC
- Ecuador
- Prior art keywords
- ig1ur5
- selective
- migraine
- receiver
- treatment
- Prior art date
Links
- 208000019695 Migraine disease Diseases 0.000 title abstract 2
- 206010027599 migraine Diseases 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 abstract 3
- 229940044551 receptor antagonist Drugs 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención proporciona un procedimiento para tratar o prevenir la migraña que comprende administrar a un paciente en necesidad del mismo una cantidad eficaz de un antagonista selectivo del receptor iG1uR5 La presente invención proporciona además nuevos compuestos funcionales como antagonistas selectivos del receptor iG1uR5, asi como composiciones y formulaciones que comprenden dichos antagonistas selectivos del receptor iG1uR5.The present invention provides a method for treating or preventing migraine which comprises administering to an patient in need thereof an effective amount of a selective iG1uR5 receptor antagonist. The present invention further provides new functional compounds as selective iG1uR5 receptor antagonists, as well as compositions. and formulations comprising said selective iG1uR5 receptor antagonists.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003564 ECSP003564A (en) | 2000-07-06 | 2000-07-06 | SELECTIVE ANTAGONISTS OF THE RECEIVER OF iG1uR5 FOR THE TREATMENT OF MIGRAINE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003564 ECSP003564A (en) | 2000-07-06 | 2000-07-06 | SELECTIVE ANTAGONISTS OF THE RECEIVER OF iG1uR5 FOR THE TREATMENT OF MIGRAINE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003564A true ECSP003564A (en) | 2001-04-23 |
Family
ID=42041177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003564 ECSP003564A (en) | 2000-07-06 | 2000-07-06 | SELECTIVE ANTAGONISTS OF THE RECEIVER OF iG1uR5 FOR THE TREATMENT OF MIGRAINE |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003564A (en) |
-
2000
- 2000-07-06 EC ECSP003564 patent/ECSP003564A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005107726A3 (en) | Method for the treatment of back pain | |
| CR8181A (en) | USE OF A COMBINATION OF AN INHIBITOR OF THE KINASA OF THE RECEIVER OF THE EPIDERMAL GROWTH FACTOR AND CYTOTOXIC AGENTS FOR THE TREATMENT AND INHIBITION OF CANCER | |
| TR200200066T2 (en) | Selective iGluR5 receptor antagonists for the treatment of migraine | |
| BR0207526A (en) | Compound, pharmaceutical composition, and methods for treating pain, migraine, depression, anxiety, schizophrenia, parkinson's disease, or stroke | |
| PA8493701A1 (en) | COMPOUNDS TO TREAT OBESITY | |
| NI200800060A (en) | BENCIMIDAZOLS REPLACED AS CINASA INHIBITORS. | |
| ECSP045407A (en) | BENZAZOLES SUBSTITUTED AND THE USE OF THE SAME AS INHIBITORS OF QUINASA RAF | |
| JO2355B1 (en) | CGRP receptor antagonists | |
| PT1135153E (en) | USES FOR ANTAGONISTS AND AGNISTS OF EPH RECEPTORS FOR TREATING VASCULAR DISORDERS | |
| BR0112311A (en) | Active agent release compounds and compositions, unit dosage form, method for preparing said compositions and their use | |
| CR7877A (en) | DERIVATIVES OF 4-TETRAZOLIL-4-PHENYLPIPERIDINE TO TREAT PAIN | |
| ATE538103T1 (en) | QUINAZOLINONE COMPOUNDS AS ANTICANCER AGENTS | |
| GT199900189A (en) | 5-HT1 AND METOCLOPRAMIDE RECEPTORS AGONISTS FOR THE TREATMENT OF MIGRAINE. | |
| BR0007487A (en) | D-diphenyl ureas substituted with w-carboxy aryls as raf kinase inhibitors | |
| AR052774A1 (en) | IMMUNOTHERAPY FOR AUTOIMMUNE DISORDERS | |
| EA200300183A1 (en) | NEW COMBINATION OF THE AGONIST (5-TH2) AND THE ANTAGONIST (5-HT6) SEROTONIN AS A PHARMACEUTICAL COMPOSITION | |
| UY27800A1 (en) | USE OF SENAL TRANSDUCTION INHIBITORS INDIRECTED BY EGFR FOR THE TREATMENT OF HYPERPLASIA OF THE BENIGNA PROSTATE (HPS) / PROSTATE HYPERTROPHY. | |
| BR0209327A (en) | Composition for treatment of drug-induced constipation | |
| DK1551803T3 (en) | Azabicyclo derivatives as muscarinic receptor antagonists | |
| PE20020909A1 (en) | A COMBINATION OF COMBRETASTATIN AND ANTI-CANCER AGENTS | |
| MXPA06007007A (en) | Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours. | |
| MXPA03004547A (en) | Selective dopamine d4 receptor agonists for treating sexual dysfunction. | |
| WO2002056010A3 (en) | Methods for the treatment of ibs | |
| UY28925A1 (en) | NEW DERIVATIVES OF AMINOPIRIDINE AND ITS USE AS DRUGS | |
| BR0111785A (en) | Compositions and methods for treating candidiasis |